Primary experimental recordPositive observation

PMC10043419::ACT000059

MPI-C

Evidence text

Paper-level observation

The results presented in Figure 2F manifested the percentage of apoptotic MB49 cells increased to 44.3% in OMV^MPI-C group, much higher than the 8.43% in PBS group and 11.0% in OMV^WT group.

figureConfidence: medium

Assay observation

Activity

Anticancer

Subtype

Cytotoxic

Measure

percent_inhibition

Comparator

Raw observation

44.3%

Normalized measurement

=44.3%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

MB49

Assay method

Not reported by source

Sequence

Not reported by source

Standardization

insufficient information

Source publication

Bioengineered bacterial outer membrane vesicles encapsulated Polybia–mastoparan I fusion peptide as a promising nanoplatform for bladder cancer immune-modulatory chemotherapy

Frontiers in Immunology · 2023

DOI 10.3389/fimmu.2023.1129771 PMC10043419

Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.